Comparison between Avience Biomedicals IPO and Rapid Fleet Management IPO.
Avience Biomedicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Rapid Fleet Management IPO is a SME Bookbuilding proposed to list at NSE SME.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | MLB Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹0.00 Cr whereas the issue size of the Rapid Fleet Management IPO is up to ₹35.77 Cr. The final issue price of Avience Biomedicals IPO is and of Rapid Fleet Management IPO is ₹192.00 per share.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹183.00 per share | |
| Issue Price (Upper) | ₹192.00 per share | |
| Issue Price (Final) | ₹192.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | |
| Fresh Issue Size | 15,27,600 shares | 18,63,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹35.77 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,27,600 shares | 18,63,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹35.77 Cr |
Avience Biomedicals IPO opens on , while Rapid Fleet Management IPO opens on Mar 21, 2025. The closing date of Avience Biomedicals IPO and Rapid Fleet Management IPO is , and Mar 25, 2025, respectively.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Anchor Bid Date | Mar 20, 2025 | |
| Issue Open | Mar 21, 2025 | |
| Issue Close | Mar 25, 2025 | |
| Basis Of Allotment (Tentative) | Mar 26, 2025 | |
| Initiation of Refunds (Tentative) | Mar 27, 2025 | |
| Credit of Share (Tentative) | Mar 27, 2025 | |
| Listing date (Tentative) | Mar 28, 2025 | |
| Anchor Lockin End date 1 | Apr 25, 2025 | |
| Anchor Lockin End date 2 | Jun 24, 2025 |
Avience Biomedicals IPO P/E ratio is , as compared to Rapid Fleet Management IPO P/E ratio of 12.25.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Avience Biomedicals Ltd.'s revenue increased by 89% and profit after tax (PAT) rose by 239% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.85 | 97.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.37 | 67.54 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹142.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 50.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 43.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | 0.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹15.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 50.14 | 40.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 0 shares while in Rapid Fleet Management IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Avience Biomedicals IPO and 3,72,600 shares in Rapid Fleet Management IPO.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,58,600 shares | |
| Market Maker Reservation | 80,400 shares | 4,21,800 shares |
| QIB | 0 shares | 3,72,600 shares |
| NII | 0 shares | 2,79,600 shares |
| RII | 0 shares | 6,52,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 18,63,000 shares |
Avience Biomedicals IPO subscribed in total, whereas Rapid Fleet Management IPO subscribed 1.65x.
| Avience Biomedicals IPO | Rapid Fleet Management IPO | |
|---|---|---|
| QIB (times) | 1.07x | |
| NII (times) | 4.38x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.81x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.65x |
